UPLChemicals

UPL Limited

Pesticides & Agrochemicals · ISIN INE628A01036 · BSE 512070 · NSE EQ · FV ₹2
Last price
₹555
+0.75%today
What this company does

UPL Limited operates in Pesticides & Agrochemicals, part of the Chemicals sector. It booked ₹10,181 cr of revenue in its latest quarter (Q1 FY27) and kept 0.1% of sales as profit. It is the largest of 9 Pesticides & Agrochemicals companies we track, by market value.

UPL is a leading global provider of sustainable agricultural and chemical markets: UPL Corporation handles the products and solutions, serving growers in more than international crop protection business, focusing on high- 140 countries with an annual revenue of $6 billion.
Their stated vision

is to be a global icon for spanning advanced seeds and post-harvest treatments, pioneered high-impact agri-solutions conventional crop protection, BioSolutions, specialty technology growth and innovation globally, consistently navigating chemistries and high-tech agronomic services.

Their stated mission

is to change the game, tailored approaches.

In the report:
35out of 100
Equitytale Health Score
Strained

Healthier than 35% of companies in Chemicals, on all six measures of filed financials. Each measure is ranked against the 35–44 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
37

At close. Not part of the score.

Profitability & returns8

How much profit it earns on the money it employs

Balance sheet21

How much it owes, and whether earnings cover the interest

Cash quality87

Whether reported profit actually arrives as cash

Growth & consistency44

Whether sales and profit have grown, and how steadily

Valuation6

What today's price implies, against our models or its peers

Governance & risk86

How much of the promoters' stake is pledged, and how much they hold

Is this company doing well?
not investment advice
Strengths
Sales up 10% vs last year
No promoter shares pledged
Watch-outs
! Currently loss-making
! Thin 0.1% net margin
! Low 0.1% return on equity
! Operating cash flow is negative

What if I invest in UPL?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 12% a year, it would become
₹22.40 lakh

The slider starts at 12%, taken from this company's own free-cash-flow trend. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹555 +0.75%
latest close · 2026-09-17
1-year return
-22.9%
52-wk low ₹55052-wk high ₹848
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio1,155.7High
LowAverageHigh
P/B ratio9.73High
Below bookModerateHigh
EV / EBITDA53.3High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity0.1%Weak
WeakFairStrong ▸15%
Return on capital5.5%Weak
WeakFairStrong
Net margin0.1%Thin
ThinDecentStrong
EBITDA margin16.3%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.53Moderate
LowModerateHigh ▸1
Interest cover1.0×Risky
RiskyOkayStrong ▸5×
Current ratio1.21Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹3.37 L cr
Book value
₹57
EPS
₹0.12
latest quarter
Net debt
₹16,071 cr
owes more than its cash
Enterprise value
₹3.54 L cr
EBITDA
₹6,632 cr
annualised
EBIT
₹3,304 cr
annualised
Operating margin
8.1%
Return on assets
0.0%
Earnings yield
0.09%
P/S
8.29
Sales / share
₹66.9
Tax rate
Face value
₹2
Shares
608.3 cr
Working capital
₹7,414 cr
Current assets
₹42,162 cr
Current liabilities
₹34,748 cr
Delivery %
55.5%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2026 report & filings
not investment advice
Hard to value confidentlyLow confidence
The market price is far above what these earnings- and book-based models support — a fast-growing or asset-light business can trade well above them for years, so we won't put a confident number on how overpriced it is.
Models span ₹55₹62, midpoint ₹59

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹10,181 cr
Other Income₹217 cr
Total Income₹10,398 cr
Cost of Materials₹5,621 cr
Purchases of Stock-in-Trade₹1,472 cr
Inventory Change (±)₹-2,778 cr
Employee Benefit Expense₹1,527 cr
Finance Costs₹852 cr
Depreciation & Amortisation₹832 cr
Other Expenses₹2,889 cr
Total Expenses₹10,415 cr
Exceptional Items₹-9 cr
Profit before Tax₹-26 cr
Tax Expense₹-36 cr
Share of JV / Associates₹-83 cr
Net Profit₹-73 cr
Net margin on total income-0.7%
Where the money goes · Q1 FY27
% of total spend
Materials + stock-in-trade₹4,315 cr41.4%
Employee benefit expense₹1,527 cr14.7%
Finance costs₹852 cr8.2%
Depreciation & amortisation₹832 cr8.0%
Other expenses₹2,889 cr27.7%
Total income ₹10,398 cr

The company made a net loss of ₹73 cr this quarter — income covered only 100 of every ₹100 it spent on costs and tax.

Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue12,269 cr18,335 cr10,181 cr
Total income12,361 cr18,513 cr10,398 cr
Expenses11,553 cr16,528 cr10,415 cr
Profit before tax752 cr1,969 cr-26 cr
Tax181 cr598 cr-36 cr
Net profit (owners' share)396 cr1,061 cr10 cr
Net margin (owners' share, on revenue)3.2%5.8%0.1%
EPS (₹)4.6912.570.12
YoY (latest quarter): total income +11.1% · net profit
Balance sheet & cash flow · as of Mar 2026
Moderate debt
Total assets
₹95,205 cr
Shareholder equity
₹34,696 cr
parent shareholders
Total debt
₹22,046 cr
Cash
₹5,975 cr
Cash flow · H1 FY26
Operating
₹-4,811 cr
Investing
₹-793 cr
Financing
₹-155 cr
Peer comparison
Pesticides & Agrochemicals · by market value
CompanyPriceMarket capP/E
UPL Limitedthis company₹555₹3.37 L cr1,155.7
PI Industries Limited₹2,307₹35,066 cr35.8
Sumitomo Chemical India Limited₹455₹22,734 cr26.5
Sharda Cropchem Limited₹742₹6,692 cr19.0
Dhanuka Agritech Limited₹982₹4,428 cr14.7
Rallis India Limited₹204₹3,971 cr
NACL Industries Limited₹149₹3,488 cr41.8
Bhagiradha Chemicals & Industries Limited₹248₹3,215 cr60.2
GSP Crop Science Limited₹484₹2,252 cr21.3
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
1.08%
trailing 12 months
Dividend / share (TTM)
₹6
Last dividend
₹6
ex 17 Jul 2026
ActionDetailEx-date
Dividend₹6 / share17 Jul 2026
Dividend₹6 / share11 Jul 2025
Rights issue8:126 Nov 2024
Dividend₹1 / share12 Aug 2024
Dividend₹10 / share3 Aug 2023
Dividend₹10 / share27 Jul 2022
Who owns it · 2026-06-30
No pledge
Promoter
33.5%
FII / Foreign
43.7%
DII / Domestic
14.3%
Retail / others
8.5%
Promoter stake up 1.0% over the last 12 quarters.
Smart-money activity
Insider trades
BoughtRumi Family Private Trust · Other10,000 · ₹62.8 L2 Mar 26
SoldKartik Bhatia · Employees/Designated Employees500 · ₹3.5 L16 Sep 25
SoldJasmin Kartik Bhatia · Immediate relative500 · ₹3.5 L10 Sep 25
Bulk / block deals
short · NSE3658 Sep 26
short · NSE12 Sep 26
short · NSE8227 Aug 26
Stake changes
BoughtDemuric Holdings Private Limited along with pac · promoter→ 33.57% · 18.08 cr21 Jul 26
BoughtDemuric Holdings Private Limited · promoter→ 22.03% · 18.08 cr21 Jul 26
BoughtLazard Asset Management LLC→ 5.02% · 8.55 L8 Jun 26
Promoter pledges
Released360 One Prime Ltd22.25 L · 0.26% held30 Dec 24
Released360 One Prime Ltd22.25 L · 0.26% held30 Dec 24
Pledged360 One Prime Limited22.25 L · 0.00% held19 Sep 24
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Special shareholder meeting · 31 Mar 2026
See the official result
1
Approval for material related party transactions pertaining to sale of materials and providing functional support services by UPL Limited to its subsidiaries
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
44.06 cr votes for, 21,567 against · 0% of mutual funds and other big investors said no
2
Approval for material related party transactions pertaining to sale of materials and providing functional support services by Arysta LifeScience Benelux SRL to UPL Europe Supply Chain GmbH
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
44.06 cr votes for, 21,582 against · 0% of mutual funds and other big investors said no
3
Approval for material related party transactions pertaining to sale of materials by UPL Europe Supply Chain GmbH to UPL France
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
44.06 cr votes for, 21,567 against · 0% of mutual funds and other big investors said no
4
Approval for material related party transactions pertaining to sale of materials by UPL Agricultural Product Trading FZE to UPL Do Brasil – Industria e Comércio de Insumos Agropecuários S.A.
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
44.06 cr votes for, 21,582 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 89 named members
owning 33.5% between them · as of 2026-06-30
Nerka Chemicals Pvt Ltd21.41%
Uniphos Enterprises Limited4.94%
Suresight Ventures Limited1.74%
Harmonic Ventures Limited1.61%
Jaidev Rajnikant Shroff1.37%
Vikram Rajnikant Shroff1.14%
Demuric Holdings Private Limited0.62%
Shilpa P Sagar0.45%
Business done with them
FY2026 · 3 of the group
The company paid ₹73 cr to companies in the promoter group last year — about 0.1% of its ₹51,839 cr revenue.
Ultima Search
Bought goods from them
₹30 cr
company paid
JRF International Limited
Bought property or assets from them
₹21 cr
company paid
JRF International Limited
Paid them for services
₹20 cr
company paid
JRF America Inc
Other payments to them
₹2 cr
company paid

The company also transacted with 21 other related parties — subsidiaries, joint ventures, directors and others — that we could not match by name to the promoter list above. Some may still be connected to the family; we only count the ones the filings let us match with certainty.

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

Money it raised, and what it did with it

When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.

₹3,378 cr raised in Dec 2024 by offering new shares to existing shareholders

As of Dec 2025, the company says it has spent 99% of what it set aside, leaving ₹33 cr still to be spent. Care Ratings Limited watches the spending on the exchange’s behalf.

Prepayment, repayment and / or redemption of all, or a portion of, certain outstanding borrowings availed by our Company and certain of our Subsidiaries
99%
₹2,990 cr of ₹3,009 cr
General Corporate Purposes
98%
₹332 cr of ₹338 cr
Issue related expenses
74%
₹23 cr of ₹31 cr
Spent by quarter: 1%99% (to Dec 2025)

Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.